Next, to assess whether the upregulation of CCR9 influences the migration and invasion, and chemotaxis abilities of the T-ALL cells, in vitro transwell migration/chemotaxis and invasion assays were performed. The gene discussed is CCR9; the disease is acute lymphoblastic leukemia.